Miklja, Z., Yadav, V. N., Cartaxo, R. T., Siada, R., Thomas, C. C., Cummings, J. R., . . . Sarkaria, J. N. (2020). Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma. Journal of Clinical Investigation, 130(10), 5313. https://doi.org/10.1172/JCI133310
Chicago Style (17th ed.) CitationMiklja, Zachary, et al. "Everolimus Improves the Efficacy of Dasatinib in PDGFRα-driven Glioma." Journal of Clinical Investigation 130, no. 10 (2020): 5313. https://doi.org/10.1172/JCI133310.
MLA (9th ed.) CitationMiklja, Zachary, et al. "Everolimus Improves the Efficacy of Dasatinib in PDGFRα-driven Glioma." Journal of Clinical Investigation, vol. 130, no. 10, 2020, p. 5313, https://doi.org/10.1172/JCI133310.
Warning: These citations may not always be 100% accurate.